3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
22
Lung Neoplasms
10
Stomach Neoplasms
9
Neoplasm Metastasis
8
Esophageal Neoplasms
7
Breast Neoplasms
7
Colorectal Neoplasms
6
Nasopharyngeal Carcinoma
5
Leukemia, Myeloid, Acute
5
Triple Negative Breast Neoplasms
4
Small Cell Lung Carcinoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Adenocarcinoma Of Esophagus
4
Uterine Cervical Neoplasms
3
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Mouth Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Carcinoma, Squamous Cell
2
Carcinoma, Ovarian Epithelial
2
Anatomic Stage II Breast Cancer AJCC v8
2
Interventions
Specimen Handling
6
pembrolizumab
4
enfortumab vedotin
4
Magnetic Resonance Spectroscopy
4
Nivolumab
3
Gemcitabine
3
cabozantinib
2
avelumab
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
tremelimumab
1
tocilizumab
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Watchful Waiting
1
Standard of Care
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Plasma Exchange
1
Observation
1
Lenalidomide
1
Doxorubicin
1
Cystoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Drug Therapy
×
90 days
×
Clear all
No trials found.